相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin
Grant H. Petersen et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Antibody-drug conjugates for cancer therapy
Anish Thomas et al.
LANCET ONCOLOGY (2016)
Gulp1 is associated with the pharmacokinetics of PEGylated liposomal doxorubicin (PLD) in inbred mouse strains
Gina Song et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Mechanism of hard-nanomaterial clearance by the liver
Kim M. Tsoi et al.
NATURE MATERIALS (2016)
Erratum: Cancer nanomedicine: is targeting our target?
Twan Lammers et al.
Nature Reviews Materials (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Lessons in simplicity that should shape the future of drug delivery
Koen Raemdonck et al.
NATURE BIOTECHNOLOGY (2015)
Liposomal Delivery of Dexamethasone Attenuates Prostate Cancer Bone Metastatic Tumor Growth In Vivo
Jan Kroon et al.
PROSTATE (2015)
Extracellular vesicles as drug delivery systems: Lessons from the liposome field
Roy van der Meel et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Remote loading of preencapsulated drugs into stealth liposomes
Surojit Sur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
Roy van der Meel et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Analysis on the current status of targeted drug delivery to tumors
Il Keun Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2012)
分享论文
